APPLICATION
ANDA076063
TYPE
ANDA
ORIGINAL APPROVAL
2002-07-01
LATEST ACTION
2024-04-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LISINOPRILDiscontinued
LISINOPRIL 30MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 20MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 5MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 40MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 10MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 2.5MG · TABLET · ORAL
Approval history
2024-04-11Labeling · Supplement 67 · standardAP
2020-05-13Labeling · Supplement 65 · standardAP
2016-09-15Labeling · Supplement 63 · standardAP
2016-09-15Labeling · Supplement 61 · standardAP
2016-09-15Labeling · Supplement 64 · standardAP
2016-09-15Labeling · Supplement 60 · standardAP
2015-06-04Labeling · Supplement 57 · standardAP
2015-06-04Labeling · Supplement 55 · standardAP
2015-06-04Labeling · Supplement 53 · standardAP
2015-06-04Labeling · Supplement 51 · standardAP
2015-06-04Labeling · Supplement 56 · standardAP
2015-06-04Labeling · Supplement 48 · standardAP
2015-06-04Labeling · Supplement 54 · standardAP
2013-08-14Labeling · Supplement 49 · standardAP
2013-08-05Manufacturing (CMC) · Supplement 40AP
2013-02-28Labeling · Supplement 47 · standardAP
2013-02-28Labeling · Supplement 45 · standardAP
2013-02-28Labeling · Supplement 42AP
2010-02-17Labeling · Supplement 38AP
2009-09-10Labeling · Supplement 35AP
2009-08-21Labeling · Supplement 31AP
2008-01-28Labeling · Supplement 33AP
2007-06-25Labeling · Supplement 29AP
2007-02-16Labeling · Supplement 19AP
2006-03-13Labeling · Supplement 13AP
2006-03-13Labeling · Supplement 11AP
2003-06-27Labeling · Supplement 3AP
2003-06-27Manufacturing (CMC) · Supplement 2AP
2002-07-01OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.